RA Capital Management »

Boundless Bio shares owned by RA Capital Management

Quarter-by-quarter ownership of Boundless Bio shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Boundless Bio

Tip: Access up to 7 years of quarterly data

All positions including Boundless Bio held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Boundless Bio by RA Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $31M 2.2M 14.25

More positions owned by RA Capital Management

Ascendis Pharma A/s - SH (ASND)
Vaxcyte SH (PCVX)
Legend Biotech Corp- SH (LEGN)
Janux Therapeutics SH (JANX)
Aerovate Therapeutics SH (AVTE)
Rhythm Pharmaceuticals SH (RYTM)
Evolent Health Inc - A SH (EVH)
Newamsterdam Pharma Co Nv SH (NAMS)
Rxsight SH (RXST)
Tyra Biosciences SH (TYRA)
Edgewise Therapeutics SH (EWTX)
4d Molecular Therapeutics In SH (FDMT)
Biogen SH (BIIB)
Pepgen SH (PEPG)
Geron Corp SH (GERN)

View all positions for RA Capital Management

Top funds holding Boundless Bio

FMR
RA Capital Management
Nextech Invest
Wellington Management Company
Redmile Group
Sectoral Asset Management
Citadel Advisors
Boxer Capital
Federated Investors
Ensign Peak Advisors
Silverarc Capital Management
Alyeska Investment Group
Altium Capital Management
Logos Global Management
BlackRock

View all funds holding Boundless Bio